AstraZeneca CEO Keeping Promises

AstraZeneca CEO keeping promises
Oct. 8, AstraZeneca enters worldwide licensing deal with Ardelyx, California, for $ 35 million up front with development milestones of $ 237.5 million, for treatment of renal disease. • Dec. 11, AstraZeneca partners with Isis Pharmaceuticals, California …
Read more on The News Journal

East Coast Newport Academy, an Adolescent Facility, to Open in Bethlehem
The idea came in 2008 from his own personal experience dealing with alcohol addiction and witnessing his siblings struggle with depression, which led to a suicide attempt, Mr. Monroe said. Having been in and out of a handful of treatment centers, Mr.
Read more on Litchfield County Times

China Biotech In Review: WuXi Laboratory The Only CLIA-Certified Clinical Lab …
Eddingpharm in-licensed greater-China rights to a novel osteoporosis treatment from Ablynx [BR: ABLX], a Belgium biopharma. The drug candidate, ALX-0141, is an anti-RANKL nanobody that has successfully completed a Phase I double-blind trial.
Read more on Seeking Alpha

Betty Ford Center's mission to grow with merger
That vision is now being rewritten as the world-renowned drug and alcohol addiction treatment center merges with the Hazelden Foundation, a much larger program in Minnesota that's built its reputation by expanding into multiple states. The new Hazelden …
Read more on USA TODAY

Related Drug Treatment Programs In California Information…